Tourmaline Oil is rated a Strong Buy citing insider buying, strategic LNG exposure, and a 4.66% yield. Read more on TRMLF ...

Choosing the best flat iron or curling wand for your hair can actually be much more difficult than it seems. Besides how many different brands and settings exist, there are also different types of ...

Tourmaline has reported positive net income since 2017, reflecting its ability to generate profits even when gas prices are low. Over the next five years, the company anticipates increasing its ...

Those following along with Tourmaline Oil Corp. ( TSE:TOU ) will no doubt be intrigued by the recent purchase of ...

This energy stock offers reasonable income from its regular dividend, potentially more income from special dividends, and long-term upside prospects. The post 1 Canadian Dividend Stock Off 15% to Buy ...

The NCIB allows Tourmaline to purchase up to 19,342,343 common shares (representing 5% of its issued and outstanding common shares as of July 31, 2025) over a period of twelve months commencing on ...

Rowan Ashley Smith has often been described as "a multi-hyphenate about town." He loves work that connects him to his cultures as a gay, Jewish, multiracial trans man. Before breaking into journalism, ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Photo courtesy of Tourmaline @tourmaliiine. In the opening scenes of the activist, filmmaker, and artist Tourmaline’s short film Salacia, a split screen shows the imagined everyday lives of the ...

CRYSTALS are sources of power and may help provide a sense of balance and relief to those who believe. The Tourmaline is a gemstone that comes with a wide variety of healing properties, as well as ...

Tourmaline Bio, Inc. announced its first quarter 2025 financial results, highlighting its ongoing Phase 2 TRANQUILITY trial which is set to reveal topline data in the second quarter of 2025. The trial ...